Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 0.32 |
| ▸ | POLB | P06746 | 4/20 | 0.32 |
| ▸ | RECQL | P46063 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | ATM | Q13315 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | REN | P00797 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6983256 | 0.94 | MAPT (0.34) | MAPTNPSR1POLBRECQLALDH1A1 | |
| SCHEMBL6983187 | 0.87 | NPSR1 (0.33) | MAPTNPSR1POLBRECQLALDH1A1 | |
| SCHEMBL6986589 | 0.87 | PSMB5 (0.34) | MAPTNPSR1POLBRECQLALDH1A1 | |
| SCHEMBL6986700 | 0.83 | PSMB5 (0.36) | MAPTNPSR1POLBRECQLALDH1A1 | |
| SCHEMBL6942458 | 0.83 | ADAM17 (0.37) | MAPTNPSR1POLBRECQLALDH1A1 | |
| SCHEMBL6943368 | 0.83 | ADAM17 (0.37) | MAPTNPSR1POLBRECQLALDH1A1 | |
| SCHEMBL6985082 | 0.80 | CTSS (0.35) | MAPTPSMB5MAPK1KMT2AATM | |
| SCHEMBL6983531 | 0.79 | REN (0.41) | MAPTNPSR1POLBPSMB5MAPK1 | |
| SCHEMBL6979636 | 0.79 | ADAM17 (0.35) | MAPTNPSR1POLBRECQLALDH1A1 | |
| SCHEMBL6981635 | 0.79 | MAPT (0.35) | MAPTNPSR1POLBRECQLALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1089964-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-10-29 | — | — | EP | disclosed |
| US-6239151-B1 | TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, | HOFFMANN-LA ROCHE INC. | 2001-05-29 | — | — | US | disclosed |
| EP-1089964-A1 | HYDRAZINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2001-04-11 | — | — | EP | disclosed |
| WO-2000000465-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-01-06 | — | — | WO | disclosed |